<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Surg</journal-id><journal-id journal-id-type="iso-abbrev">Ann Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">SLA</journal-id><journal-title-group><journal-title>Annals of Surgery</journal-title></journal-title-group><issn pub-type="ppub">0003-4932</issn><issn pub-type="epub">1528-1140</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10314964</article-id><article-id pub-id-type="pmcid-ver">PMC10314964.2</article-id><article-id pub-id-type="pmcaid">10314964</article-id><article-id pub-id-type="pmcaiid">10321504</article-id><article-id pub-id-type="pmid">36728693</article-id><article-id pub-id-type="doi">10.1097/SLA.0000000000005792</article-id><article-id pub-id-type="publisher-id">ANNSURG-D-22-01885</article-id><article-version-alternatives><article-version article-version-type="pmc-version">2</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Evidence-Based Opioid Prescribing Guidelines and New Persistent Opioid Use After Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9877-9603</contrib-id><name name-style="western"><surname>Howard</surname><given-names initials="R">Ryan</given-names></name><degrees>MD, MS</degrees><xref rid="aff1" ref-type="aff">*</xref><xref rid="aff2" ref-type="aff">&#8224;</xref><xref rid="aff3" ref-type="aff">&#8225;</xref><email>rhow@med.umich.edu</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ryan</surname><given-names initials="A">Andrew</given-names></name><degrees>PhD</degrees><xref rid="aff4" ref-type="aff">&#167;</xref><email>amryan@umich.edu</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hu</surname><given-names initials="HM">Hsou Mei</given-names></name><degrees>PhD, MBA</degrees><xref rid="aff3" ref-type="aff">&#8225;</xref><email>hsoumeih@med.umich.edu</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brown</surname><given-names initials="CS">Craig S.</given-names></name><degrees>MD, MS</degrees><email>brcraig@med.umich.edu</email><xref rid="aff1" ref-type="aff">*</xref><xref rid="aff2" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Waljee</surname><given-names initials="J">Jennifer</given-names></name><degrees>MD, MPH, MS</degrees><xref rid="aff1" ref-type="aff">*</xref><xref rid="aff2" ref-type="aff">&#8224;</xref><xref rid="aff3" ref-type="aff">&#8225;</xref><email>filip@med.umich.edu</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bicket</surname><given-names initials="MC">Mark C.</given-names></name><degrees>MD, PhD</degrees><xref rid="aff3" ref-type="aff">&#8225;</xref><xref rid="aff5" ref-type="aff">&#8741;</xref><email>mbicket@med.umich.edu</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Englesbe</surname><given-names initials="M">Michael</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">*</xref><xref rid="aff2" ref-type="aff">&#8224;</xref><xref rid="aff3" ref-type="aff">&#8225;</xref><email>englesbe@med.umich.edu</email></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Brummett</surname><given-names initials="CM">Chad M.</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">&#8225;</xref><xref rid="aff5" ref-type="aff">&#8741;</xref><email>cbrummet@med.umich.edu</email></contrib></contrib-group><aff id="aff1">
<label>*</label>Department of Surgery</aff><aff id="aff2">
<label>&#8224;</label>Center for Healthcare Outcomes and Policy, Michigan Medicine</aff><aff id="aff3">
<label>&#8225;</label>Opioid Prescribing and Engagement Network</aff><aff id="aff4">
<label>&#167;</label>School of Public Health, University of Michigan</aff><aff id="aff5">
<label>&#8741;</label>Department of Anesthesiology, Michigan Medicine, Ann Arbor, MI</aff><author-notes><corresp><email>cbrummet@umich.edu.</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>2</day><month>1</month><year>2023</year></pub-date><volume>278</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">439997</issue-id><fpage>216</fpage><lpage>221</lpage><pub-history><event event-type="pmc-release"><date><day>05</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>06</day><month>07</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-06 10:25:21.513"><day>06</day><month>07</month><year>2023</year></date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10321504</article-id><article-id pub-id-type="doi">10.1097/SLA.0000000000005792</article-id><article-version>2</article-version><pub-date><day>02</day><month>01</month><year>2023</year></pub-date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10314964</article-id><article-id pub-id-type="doi">10.1097/SLA.0000000000005792</article-id><article-id pub-id-type="manuscript-id">NIHMS1861063</article-id><article-version>319</article-version><pub-date><day>02</day><month>01</month><year>2023</year></pub-date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0</ext-link> (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>
</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="sla-278-0216.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sla-278-0216.pdf"/><abstract><title>Objective:</title><p>Evaluate the association of evidence-based opioid prescribing guidelines with new persistent opioid use after surgery.</p><sec><title>Summary Background Data:</title><p>Patients exposed to opioids after surgery are at risk of new persistent opioid use, which is associated with opioid use disorder and overdose. It is unknown whether evidence-based opioid prescribing guidelines mitigate this risk.</p></sec><sec><title>Methods:</title><p>Using Medicare claims, we performed a difference-in-differences study of opioid-naive patients who underwent 1 of 6 common surgical procedures for which evidence-based postoperative opioid prescribing guidelines were released and disseminated through a statewide quality collaborative in Michigan in October 2017. The primary outcome was the incidence of new persistent opioid use, and the secondary outcome was total postoperative opioid prescription quantity in oral morphine equivalents (OME).</p></sec><sec><title>Results:</title><p>We identified 24,908 patients who underwent surgery in Michigan and 118,665 patients who underwent surgery outside of Michigan. Following the release of prescribing guidelines in Michigan, the adjusted incidence of new persistent opioid use decreased from 3.29% (95% CI 3.15-3.43%) to 2.51% (95% CI 2.35-2.67%) in Michigan, which was an additional 0.53 (95% CI 0.36-0.69) percentage point decrease compared with patients outside of Michigan. Simultaneously, adjusted opioid prescription quantity decreased from 199.5 (95% CI 198.3-200.6) mg OME to 88.6 (95% CI 78.7-98.5) mg OME in Michigan, which was an additional 55.7 (95% CI 46.5-65.4) mg OME decrease compared with patients outside of Michigan.</p></sec><sec><title>Conclusions:</title><p>Evidence-based opioid prescribing guidelines were associated with a significant reduction in the incidence of new persistent opioid use and the quantity of opioids prescribed after surgery.</p></sec></abstract><kwd-group><title>Keywords:</title><kwd>opioids</kwd><kwd>surgery</kwd><kwd>new persistent opioid use</kwd><kwd>prescribing</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>New persistent postoperative opioid use occurs when an opioid-naive patient receives a postoperative opioid prescription meant for short-term use but continues to fill additional opioid prescriptions for months after this initial exposure.<sup><xref rid="R1" ref-type="bibr">1</xref>&#8211;<xref rid="R4" ref-type="bibr">4</xref></sup> New persistent opioid use after surgery is associated with an increased long-term risk of complications, opioid use disorder, overdose, and death.<sup><xref rid="R5" ref-type="bibr">5</xref>&#8211;<xref rid="R9" ref-type="bibr">9</xref></sup> Chronic opioid use after surgery also burdens the healthcare system, as these prescriptions are ultimately managed by primary care physicians and patients have increased healthcare utilization and spending.<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup> Recognition of these risks has led to the development of evidence-based postoperative opioid prescribing guidelines.<sup><xref rid="R12" ref-type="bibr">12</xref>&#8211;<xref rid="R15" ref-type="bibr">15</xref></sup> These guidelines have been shown to reduce the quantity of opioids prescribed after surgery without compromising patient satisfaction or pain control.<sup><xref rid="R16" ref-type="bibr">16</xref></sup>
</p><p>Despite the growing adoption of postoperative opioid prescribing guidelines, to date, no study has assessed whether these guidelines reduce the risk of developing chronic opioid use after surgery.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> Given that over 50 million operations are performed annually in the United States and most involve a postoperative opioid prescription, even a small reduction in the incidence of new persistent opioid use could have major implications for prescribing practice and patient safety.<sup><xref rid="R18" ref-type="bibr">18</xref></sup>
</p><p>Therefore, we evaluated the change in new persistent opioid use after surgery following the statewide implementation of evidence-based opioid prescribing guidelines. In 2017, the Opioid Prescribing Engagement Network (OPEN) at the University of Michigan released evidence-based prescribing guidelines for 6 common surgical procedures. These were disseminated across 70 hospitals in Michigan, responsible for the majority of surgical care in the state. We hypothesized that the release of these guidelines would be associated with a decrease in the incidence of new persistent opioid use in Michigan compared with the rest of the United States.</p><sec sec-type="methods"><title>METHODS</title><p>In June 2016, OPEN was established to address the problem of excessive opioid prescribing and pain management after acute care. Consisting of a partnership between clinicians, public health leaders, the Michigan Department of Health and Human Services, and Blue Cross Blue Shield of Michigan, OPEN collected data on patient-reported opioid use after surgery from hospitals throughout Michigan and used these data to develop evidence-based prescribing guidelines.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> In October 2017, OPEN released postoperative opioid prescribing guidelines for 6 procedure categories: laparoscopic cholecystectomy, laparoscopic appendectomy, minor hernia repair (open and laparoscopic inguinal, femoral, umbilical, and epigastric hernia repair), major hernia repair (open and laparoscopic ventral/incisional hernia repair), colectomy (open and laparoscopic), and hysterectomy (open, laparoscopic, and vaginal) (Supplemental Table 1, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>).<sup><xref rid="R16" ref-type="bibr">16</xref></sup> These guidelines recommended prescribing a quantity of opioids equivalent to no more than the 75th percentile of patient-reported opioid use.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> Guidelines were disseminated via email, in-person presentations, video presentations, and web-based materials to 70 hospitals in Michigan through the Michigan Surgical Quality Collaborative (MSQC).<sup><xref rid="R21" ref-type="bibr">21</xref></sup> OPEN guidelines were formally endorsed by the MSQC as a quality improvement initiative.</p><sec><title>Data Source and Study Cohort</title><p>We used 100% fee-for-service Medicare claims (Part A, Part B, and Part D) in Michigan and a 20% national sample of fee-for-service Medicare claims outside of Michigan to identify patients undergoing surgery from January 1, 2013 to June 30, 2019. The study end date was chosen based on data availability and to allow for the evaluation of a 2-year post-intervention period. We included adult (age &#8805;18&#160;y) Medicare beneficiaries who underwent any of the above surgical procedures for which OPEN had developed opioid prescribing guidelines (Supplemental Table 2, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>).</p><p>We identified only opioid-naive patients by excluding patients who filled 1 or more opioid prescriptions in the 12 months to 31 days before surgery.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> Patients were also excluded if they did not have continuous enrollment for at least 12 months before surgery and 6 months after surgery, were not discharged home after surgery, were still in the hospital on postoperative day 30, or underwent another surgery within 6 months of their index operation.</p></sec><sec><title>Outcomes and Covariates</title><p>The primary outcome was the incidence of new persistent opioid use after surgery. This was defined based on previously published criteria as filling at least 1 opioid prescription between postoperative days 4 to 90 and filling at least 1 additional opioid prescription between postoperative days 91 to 180.<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> The secondary outcome was the quantity of opioids prescribed after surgery. This was defined as the total milligrams of oral morphine equivalents (OME) dispensed in the 6 months after surgery in Part D pharmacy claims. Conversion to OME was performed to standardize differing potency between individual opioids.<sup><xref rid="R24" ref-type="bibr">24</xref></sup>
</p><p>The exposure of interest was the occurrence of surgery in Michigan after the initiation of opioid mitigation strategies in 2016. Based on prior frameworks related to opioid prescribing, other patient covariates included age, sex, race and ethnicity, Elixhauser comorbidity index, history of tobacco use, alcohol or substance use disorders, mental health disorders, and pain disorders.<sup><xref rid="R25" ref-type="bibr">25</xref>&#8211;<xref rid="R27" ref-type="bibr">27</xref></sup> Clinical covariates included the surgical procedure type, year of surgery, and admission status (inpatient vs. outpatient).</p></sec><sec><title>Statistical Analysis</title><p>Descriptive statistics were calculated for patients who underwent surgery in Michigan and the rest of the United States. The main analysis of this study was a difference-in-differences model to evaluate the association of OPEN prescribing guidelines (released October 2017) with new persistent opioid use and opioid prescription quantity after surgery in Michigan.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> Since OPEN began community outreach in June 2016, we also evaluated the change in outcomes after this time point. Difference-in-difference analysis was used to account for ongoing trends in new persistent opioid use and opioid prescription quantity, both of which had been previously demonstrated to be decreasing nationally.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup>
</p><p>Because there were differences in trends in outcomes between Michigan and non-Michigan patients before June 2016, we first calculated adjusted trends in new persistent opioid use and postoperative opioid prescription quantity for both groups. This followed previously described methods for calculating trend-adjusted models.<sup><xref rid="R30" ref-type="bibr">30</xref></sup> We next performed a difference-in-differences analysis on trend-adjusted outcomes to assess the differential change in each outcome for patients who underwent surgery in Michigan compared with patients who underwent surgery outside of Michigan. To do so, we estimated a fixed effects linear regression model that included all covariates above, an indicator for the operation occurring in Michigan, an indicator for each time period (before June 2016, between July 2016 and September 2017, and after October 2017), and an interaction term between Michigan and each time period indicator.</p><p>We also performed 4 sensitivity analyses. First, to mitigate the potential effect of regional variation in the United States, we performed the same difference-in-differences analysis using 11 states in the US Midwest as the comparator group (Illinois, Indiana, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin). Second, we further limited the geographic proximity of the comparator group and performed the same difference-in-differences analysis using Indiana and Wisconsin as comparators. Indiana and Wisconsin were chosen since Indiana did not have a collaborative quality improvement program like MSQC, and although Wisconsin had a collaborative quality improvement program, it did not focus on opioids during the study period. Third, given that patients with a diagnosis of cancer may be more likely to fill future opioid prescriptions due to cancer-related pain, which confounds accurate identification of new persistent opioid use, we performed the same difference-in-differences analysis excluding patients with a diagnosis of cancer. Finally, since patients with substance and drug use disorders are at increased risk of new persistent opioid use, we performed the same difference-in-differences analysis excluding patients with this diagnosis.</p><p>All statistical tests were performed using Stata version 16 (StataCorp LLC). Tests were 2-sided and significance was set to <italic toggle="yes">P</italic>&lt;0.05. All statistical models used robust standard errors to account for clustering at the state level. The Institutional Review Board of the University of Michigan deemed this study of de-identified secondary data exempt from review and waived the requirement for informed consent. This study follows a preregistered study protocol available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://dx.doi.org/10.17504/protocols.io.bwy6pfze" ext-link-type="uri">https://dx.doi.org/10.17504/protocols.io.bwy6pfze</ext-link> and follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines.<sup><xref rid="R31" ref-type="bibr">31</xref></sup>
</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>We identified 24,908 opioid-naive patients who underwent 1 of the selected procedures in Michigan and 118,665 patients who underwent 1 of the selected procedures outside of Michigan between January 1, 2013 to June 30, 2019 (Supplemental Figure 1, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>). The mean age of patients in Michigan was 70.1 (11.6) years, and 11,774 (47.3%) patients were female. The mean age of patients outside of Michigan was 70.6 (10.9) years, and 57,210 (48.2%) patients were female. Full patient characteristics are displayed in Table <xref rid="T1" ref-type="table">1</xref>.</p><table-wrap position="float" id="T1" orientation="portrait"><label>TABLE 1</label><caption><p>Cohort Characteristics</p></caption><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2" axis="1">2013&#8211;2019</th></tr><tr><th align="left" rowspan="1" colspan="1" axis="1">Characteristic</th><th align="center" rowspan="1" colspan="1" axis="1">Michigan (N=24,908), n (%)</th><th align="center" rowspan="1" colspan="1" axis="1">Non-MI US (N=118,665), n (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (mean (SD))</td><td align="char" char="(" rowspan="1" colspan="1">70.1 (11.6)</td><td align="char" char="(" rowspan="1" colspan="1">70.6 (10.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="char" char="(" rowspan="1" colspan="1">11774 (47.27)</td><td align="char" char="(" rowspan="1" colspan="1">57210 (48.2)</td></tr><tr><td align="left" rowspan="1" colspan="3">Race/Ethnicity</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Non-Hispanic White</td><td align="char" char="(" rowspan="1" colspan="1">22141 (88.89)</td><td align="char" char="(" rowspan="1" colspan="1">99615 (83.95)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Non-Hispanic Black</td><td align="char" char="(" rowspan="1" colspan="1">1717 (6.89)</td><td align="char" char="(" rowspan="1" colspan="1">6333 (5.34)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hispanic</td><td align="char" char="(" rowspan="1" colspan="1">112 (0.45)</td><td align="char" char="(" rowspan="1" colspan="1">6842 (5.77)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Other</td><td align="char" char="(" rowspan="1" colspan="1">524 (2.1)</td><td align="char" char="(" rowspan="1" colspan="1">3928 (3.31)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Unknown</td><td align="char" char="(" rowspan="1" colspan="1">414 (1.66)</td><td align="char" char="(" rowspan="1" colspan="1">1947 (1.64)</td></tr><tr><td align="left" rowspan="1" colspan="1">Elixhauser comorbidity index (mean (SD))</td><td align="char" char="(" rowspan="1" colspan="1">1.5 (6.1)</td><td align="char" char="(" rowspan="1" colspan="1">2.6 (7.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tobacco use</td><td align="char" char="(" rowspan="1" colspan="1">8482 (34.05)</td><td align="char" char="(" rowspan="1" colspan="1">38240 (32.23)</td></tr><tr><td align="left" rowspan="1" colspan="3">Mental health disorders</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Adjustment disorder</td><td align="char" char="(" rowspan="1" colspan="1">353 (1.42)</td><td align="char" char="(" rowspan="1" colspan="1">2294 (1.93)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Anxiety disorder</td><td align="char" char="(" rowspan="1" colspan="1">3175 (12.75)</td><td align="char" char="(" rowspan="1" colspan="1">19873 (16.75)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Mood disorder</td><td align="char" char="(" rowspan="1" colspan="1">3600 (14.45)</td><td align="char" char="(" rowspan="1" colspan="1">20034 (16.88)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Suicide</td><td align="char" char="(" rowspan="1" colspan="1">111 (0.45)</td><td align="char" char="(" rowspan="1" colspan="1">535 (0.45)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Disruptive disorder</td><td align="char" char="(" rowspan="1" colspan="1">241 (0.97)</td><td align="char" char="(" rowspan="1" colspan="1">1287 (1.08)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Personality disorder</td><td align="char" char="(" rowspan="1" colspan="1">109 (0.44)</td><td align="char" char="(" rowspan="1" colspan="1">618 (0.52)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Schizophrenia</td><td align="char" char="(" rowspan="1" colspan="1">652 (2.62)</td><td align="char" char="(" rowspan="1" colspan="1">3083 (2.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Other mental disorders</td><td align="char" char="(" rowspan="1" colspan="1">424 (1.7)</td><td align="char" char="(" rowspan="1" colspan="1">3832 (3.23)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Substance and drug use disorder</td><td align="char" char="(" rowspan="1" colspan="1">1988 (7.98)</td><td align="char" char="(" rowspan="1" colspan="1">9601 (8.09)</td></tr><tr><td align="left" rowspan="1" colspan="3">Pain disorders</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Arthritis</td><td align="char" char="(" rowspan="1" colspan="1">12512 (50.23)</td><td align="char" char="(" rowspan="1" colspan="1">42371 (35.71)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Back pain</td><td align="char" char="(" rowspan="1" colspan="1">3324 (13.35)</td><td align="char" char="(" rowspan="1" colspan="1">18898 (15.93)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Neck pain</td><td align="char" char="(" rowspan="1" colspan="1">1394 (5.6)</td><td align="char" char="(" rowspan="1" colspan="1">8036 (6.77)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Other pain disorder</td><td align="char" char="(" rowspan="1" colspan="1">4208 (16.89)</td><td align="char" char="(" rowspan="1" colspan="1">27880 (23.49)</td></tr><tr><td align="left" rowspan="1" colspan="3">Surgical procedure</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Laparoscopic cholecystectomy</td><td align="char" char="(" rowspan="1" colspan="1">7113 (28.56)</td><td align="char" char="(" rowspan="1" colspan="1">37263 (31.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Laparoscopic appendectomy</td><td align="char" char="(" rowspan="1" colspan="1">1067 (4.28)</td><td align="char" char="(" rowspan="1" colspan="1">6090 (5.13)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Minor hernia repair</td><td align="char" char="(" rowspan="1" colspan="1">7341 (29.5)</td><td align="char" char="(" rowspan="1" colspan="1">34100 (28.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Major hernia repair</td><td align="char" char="(" rowspan="1" colspan="1">5161 (20.72)</td><td align="char" char="(" rowspan="1" colspan="1">21966 (18.51)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Colectomy</td><td align="char" char="(" rowspan="1" colspan="1">1093 (4.39)</td><td align="char" char="(" rowspan="1" colspan="1">4574 (3.85)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hysterectomy</td><td align="char" char="(" rowspan="1" colspan="1">3133 (12.58)</td><td align="char" char="(" rowspan="1" colspan="1">14672 (12.36)</td></tr><tr><td align="left" rowspan="1" colspan="1">Inpatient surgery</td><td align="char" char="(" rowspan="1" colspan="1">17487 (70.21)</td><td align="char" char="(" rowspan="1" colspan="1">83569 (70.42)</td></tr><tr><td align="left" rowspan="1" colspan="3">Year of surgery</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;2013</td><td align="char" char="(" rowspan="1" colspan="1">2992 (12.01)</td><td align="char" char="(" rowspan="1" colspan="1">15394 (12.97)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;2014</td><td align="char" char="(" rowspan="1" colspan="1">3893 (15.63)</td><td align="char" char="(" rowspan="1" colspan="1">16828 (14.18)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;2015</td><td align="char" char="(" rowspan="1" colspan="1">3839 (15.41)</td><td align="char" char="(" rowspan="1" colspan="1">16776 (14.14)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;2016</td><td align="char" char="(" rowspan="1" colspan="1">3974 (15.95)</td><td align="char" char="(" rowspan="1" colspan="1">18195 (15.33)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;2017</td><td align="char" char="(" rowspan="1" colspan="1">3912 (15.71)</td><td align="char" char="(" rowspan="1" colspan="1">19241 (16.21)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;2018</td><td align="char" char="(" rowspan="1" colspan="1">4106 (16.48)</td><td align="char" char="(" rowspan="1" colspan="1">21039 (17.73)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;2019</td><td align="char" char="(" rowspan="1" colspan="1">2192 (8.8)</td><td align="char" char="(" rowspan="1" colspan="1">11192 (9.43)</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>Minor hernia repair=open and laparoscopic inguinal, femoral, umbilical, and epigastric hernia repair; major hernia repair=open and laparoscopic ventral/incisional hernia repair.</p></fn></table-wrap-foot></table-wrap><p>
Figure <xref rid="F1" ref-type="fig">1</xref> illustrates the adjusted incidence of new persistent opioid use during the study period. Compared with the rest of the United States, OPEN prescribing guidelines were associated with an additional 0.53 (95% CI 0.36-0.69) percentage point decrease (pp) in the incidence of new persistent opioid use in Michigan (Table <xref rid="T2" ref-type="table">2</xref>). This additional decrease in the incidence of new persistent opioid use in Michigan after the release of OPEN prescribing guidelines was significant for laparoscopic cholecystectomy (additional 0.81 [95% CI 0.34-1.29] pp), minor hernia repair (additional 0.46 [95% CI 0.25-0.66] pp), and colectomy (additional 2.76 [95% CI 1.66-3.86] pp) (Supplemental Table 3, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>). OPEN prescribing guidelines were associated with a differential increase in the incidence of new persistent opioid use after laparoscopic appendectomy (additional 1.37 [95% CI 0.27-2.47] pp) and no differential change in the incidence of new persistent opioid use after major hernia repair or hysterectomy in Michigan. The establishment of OPEN in June of 2016 was not associated with a differential change in the incidence of new persistent opioid use in Michigan.</p><fig position="float" id="F1" orientation="portrait"><label>FIGURE 1</label><caption><p>Quarterly adjusted new persistent opioid use. Adjusted incidence of new persistent opioid use and opioids prescription quantity estimated using marginal of linear regression models that included location of surgery (Michigan vs. non-Michigan), age, sex, race, and ethnicity, Elixhauser comorbidity index, history of tobacco use, alcohol or substance use disorders, mental health disorders, pain disorders, surgical procedure, year of surgery, and inpatient versus outpatient operation.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="sla-278-0216-g001.jpg"/></fig><table-wrap position="float" id="T2" orientation="portrait"><label>TABLE 2</label><caption><p>Adjusted Incidence of New Persistent Opioid Use and Opioid Prescription Quantity in Michigan Versus Non-Michigan US</p></caption><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1" axis="1"/><th align="center" rowspan="1" colspan="1" axis="1">Period 1 Pre-OPEN (Jan &#8217;13-Jun &#8217;16)</th><th align="center" rowspan="1" colspan="1" axis="1">Period 2 Post-OPEN (Jul &#8217;16-Sep &#8217;17)</th><th align="center" rowspan="1" colspan="1" axis="1">Period 3 Post-guidelines (Oct &#8217;17-Jun &#8217;19)</th><th align="center" rowspan="1" colspan="1" axis="1">Period 2 vs. period 1 change (Effect of OPEN)</th><th align="center" rowspan="1" colspan="1" axis="1">
<italic toggle="yes">P</italic>
</th><th align="center" rowspan="1" colspan="1" axis="1">Period 3 vs. period 2 change (Effect of guidelines)</th><th align="center" rowspan="1" colspan="1" axis="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="8">New persistent opioid use</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Michigan</td><td align="char" char="(" rowspan="1" colspan="1">3.38 (3.35-3.41)</td><td align="char" char="(" rowspan="1" colspan="1">3.29 (3.15-3.43)</td><td align="char" char="(" rowspan="1" colspan="1">2.51 (2.35-2.67)</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;0.09 (&#8722;0.20, 0.00)</td><td align="char" char="." rowspan="1" colspan="1">0.188</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;0.78 (&#8722;0.80, &#8722;0.76)</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Non-Michigan</td><td align="char" char="(" rowspan="1" colspan="1">2.71 (2.60-2.82)</td><td align="char" char="(" rowspan="1" colspan="1">2.44 (2.23-2.65)</td><td align="char" char="(" rowspan="1" colspan="1">2.18 (1.99-2.38)</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;0.27 (&#8722;0.48, &#8722;0.06)</td><td align="char" char="." rowspan="1" colspan="1">0.011</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;0.25 (&#8722;0.41, &#8722;0.09)</td><td align="char" char="." rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Diff-in-diff (MI vs. non-MI)</td><td align="left" rowspan="1" colspan="3"/><td align="char" char="(" rowspan="1" colspan="1">0.18 (&#8722;0.01, 0.37)</td><td align="char" char="." rowspan="1" colspan="1">0.078</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;0.53 (&#8722;0.69, &#8722;0.36)</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="8">Opioid prescription quantity</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Michigan</td><td align="char" char="(" rowspan="1" colspan="1">199.5 (198.3-200.6)</td><td align="char" char="(" rowspan="1" colspan="1">176.6 (168.3-184.9)</td><td align="char" char="(" rowspan="1" colspan="1">88.6 (78.7-98.5)</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;22.9 (&#8722;31.2, &#8722;14.5)</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;88.0 (&#8722;89.8, &#8722;86.2)</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Non-Michigan</td><td align="char" char="(" rowspan="1" colspan="1">218.3 (212.4-224.1)</td><td align="char" char="(" rowspan="1" colspan="1">186.5 (173.9-199.1)</td><td align="char" char="(" rowspan="1" colspan="1">154.5 (144.4-164.5)</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;31.8 (&#8722;44.4, &#8722;19.2)</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;32.0 (&#8722;41.1, &#8722;23.0)</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Diff-in-diff (MI vs. non-MI)</td><td align="left" rowspan="1" colspan="3"/><td align="char" char="(" rowspan="1" colspan="1">8.9 (0.4, 17.5)</td><td align="char" char="." rowspan="1" colspan="1">0.043</td><td align="char" char="(" rowspan="1" colspan="1">&#8722;55.7 (&#8722;65.4, &#8722;46.5)</td><td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>Adjusted incidence of new persistent opioid use and opioid prescription quantity estimated using marginal of linear regression models that included location of surgery (Michigan vs. non-Michigan), age, sex, race and ethnicity, Elixhauser comorbidity index, history of tobacco use, alcohol or substance use disorders, mental health disorders, pain disorders, surgical procedure, year of surgery, and inpatient vs. outpatient operation. Difference-in-differences estimated using a fixed effects linear regression model that included all covariates above, an indicator for the operation occurring in Michigan, an indicator for each time period (before June 2016, between July 2016 and September 2017, and after October 2017), and an interaction term between Michigan and each time period indicator.</p></fn></table-wrap-foot></table-wrap><p>
Figure <xref rid="F2" ref-type="fig">2</xref> illustrates adjusted postoperative opioid prescription quantity during the same time period. Compared with the rest of the United States, OPEN prescribing guidelines were associated with an additional 55.7 (95% CI 46.5-65.4) mg OME decrease in postoperative opioid prescription quantity in Michigan. This additional decrease in opioid prescription quantity in Michigan after the release of OPEN prescribing guidelines was significant for laparoscopic cholecystectomy (additional 95.3 [95% CI 74.6-116.0] mg OME), minor hernia repair (additional 42.7 [95% CI 38.2-47.2] mg OME), major hernia repair (additional 20.2 [95% CI 6.8-33.6] mg OME), colectomy (additional 78.5 [95% CI 47.0-110.0] mg OME), and hysterectomy (additional 34.3 [95% CI 1.9-66.7] mg OME). OPEN prescribing guidelines were not associated with a differential change in postoperative opioid prescription size after laparoscopic appendectomy in Michigan. The establishment of OPEN in June 2016 was associated with a differential 8.9 (95% CI 0.4-17.5) mg OME increase in postoperative opioid prescription quantity in Michigan. Supplemental Figure 2, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link> illustrates the proportion of patients who did not receive a postoperative opioid prescription in Michigan compared with the rest of the United States.</p><fig position="float" id="F2" orientation="portrait"><label>FIGURE 2</label><caption><p>Quarterly postoperative opioid prescription quantity. Adjusted opioid prescription quantity estimated using marginal of linear regression models that included the location of surgery (Michigan vs. non-Michigan), age, sex, race, and ethnicity, Elixhauser comorbidity index, history of tobacco use, alcohol or substance use disorders, mental health disorders, pain disorders, surgical procedure, year of surgery, and inpatient versus outpatient operation.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="sla-278-0216-g002.jpg"/></fig><sec><title>Sensitivity Analyses</title><p>Sensitivity analyses revealed similar differential decreases in both outcomes (Supplemental Table 4, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>). Compared with patients who underwent surgery in 11 neighboring Midwest states, OPEN prescribing guidelines were associated with an additional 0.61 (95% CI 0.30-0.91) pp decrease in the incidence of new persistent opioid use and an additional 52.3 (95% CI 32.3-72.2) mg OME decrease in postoperative opioid prescription quantity in Michigan (Supplemental Table 5, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>). Compared with patients who underwent surgery in Indiana and Wisconsin, the additional decrease in new persistent opioid use and opioid prescription quantity in Michigan was not significant (Supplemental Table 6, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>). After excluding patients with a diagnosis of cancer, OPEN prescribing guidelines were associated with an additional 0.64 (95% CI 0.44-0.84) pp decrease in the incidence of new persistent opioid use and an additional 64.2 (95% CI 53.8-74.5) mg OME decrease in postoperative opioid prescription quantity in Michigan (Supplemental Table 7, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>). Finally, after excluding patients with a diagnosis of substance and drug use disorder, OPEN prescribing guidelines were associated with an additional 0.38 (95% CI 0.21-0.54) pp decrease in the incidence of new persistent opioid use and an additional 30.9 (95% CI 24.7-37.2) mg OME decrease in postoperative opioid prescription quantity in Michigan (Supplemental Table 8, Supplemental Digital Content 1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/SLA/E401" ext-link-type="uri">http://links.lww.com/SLA/E401</ext-link>).</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Using a difference-in-differences analysis of Medicare claims, we found that the dissemination of evidence-based opioid prescribing guidelines was associated with a significant reduction in the incidence of new persistent opioid use and the quantity of opioids prescribed after surgery in Michigan compared with other US states. Specifically, the incidence of new persistent opioid use decreased by ~26%, and the quantity of opioids prescribed after surgery decreased by ~56% in Michigan, which was significantly greater than the decrease that occurred outside of Michigan during the same time period. These results suggest that evidence-based opioid prescribing guidelines are effective in reducing patients&#8217; risk of developing ongoing opioid use after surgery.</p><p>Over the last several years, surgical episode has been recognized as a major driver of opioid-related morbidity in the United States. Compared with the rest of the world, where postoperative opioid prescriptions are rare, over 80% of patients in the United States receive an opioid prescription after surgery.<sup><xref rid="R32" ref-type="bibr">32</xref>&#8211;<xref rid="R34" ref-type="bibr">34</xref></sup> These routine prescriptions exceed patients&#8217; analgesic needs and place opioid-na&#239;ve patients at risk of continued opioid use after surgery.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup> Although definitions of persistent postoperative opioid use vary, its incidence is estimated to range from 1% to 6.5% for common operations but can be as high as 20% after procedures such as cardiac surgery.<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R36" ref-type="bibr">36</xref>&#8211;<xref rid="R40" ref-type="bibr">40</xref></sup>
</p><p>Patients who transition from being opioid-naive to using opioids chronically after surgery are at increased risk of overdose and death.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> The risk of fatal overdose with long-term opioid therapy is well-documented.<sup><xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R41" ref-type="bibr">41</xref></sup> In addition, patients with chronic opioid prescriptions are over 8 times more likely to initiate injection drug use compared with opioid-naive patients.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> Finally, previously opioid-naive patients who develop chronic opioid use after surgery also experience increased healthcare utilization and expenditures, and the majority of these new prescriptions are ultimately managed by primary care physicians.<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R42" ref-type="bibr">42</xref></sup>
</p><p>To our knowledge, this is the first study to demonstrate that postoperative opioid prescribing guidelines based on patient-reported opioid use reduce the risk of new persistent opioid use after surgery. Although the incidence of new persistent use decreased nationally during the study period, patients who underwent surgery in Michigan had a greater reduction in the incidence of new persistent opioid use compared with patients undergoing the same operations outside of Michigan. The overall national decrease in new persistent opioid use after surgery has been reported in other studies and is likely related to greater opioid stewardship and awareness of the risks posed by opioids in the postoperative period.<sup><xref rid="R43" ref-type="bibr">43</xref></sup> In addition, the baseline rate of new persistent opioid use was higher in Michigan compared with other states, which may be related to a generally higher prevalence of substance use disorder in Michigan.<sup><xref rid="R44" ref-type="bibr">44</xref></sup> Despite this baseline difference, the significant difference-in-difference effect seen in Michigan suggests that prescribing guidelines play an important role in preventing opioid-naive patients from transitioning to chronic opioid use after surgery.</p><p>Our results also highlight an important relationship between the quantity of opioids prescribed after surgery and the risk of developing new persistent opioid use. For example, patients who underwent colectomy had the greatest reduction in the quantity of opioids prescribed as well as the greatest reduction in new persistent opioid use. Conversely, laparoscopic appendectomy was the only procedure without a significant decrease in prescription quantity following guideline release and also the only procedure without a significant decrease in the incidence of persistent opioid use. This is consistent with prior work demonstrating that patients who receive the largest prescriptions after surgery are at the greatest risk of persistent opioid use.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> Therefore, the most likely mechanism by which evidence-based prescribing guidelines reduce the risk of persistent postoperative opioid use is by decreasing the quantity of opioids prescribed after surgery. Importantly, prior work suggests that these reductions in prescription size do not negatively impact patient satisfaction or pain control.<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R45" ref-type="bibr">45</xref></sup>
</p><p>This study has several limitations. First, the differential change in new persistent opioid use and prescription size in Michigan may be subject to unmeasured confounders. For example, we did not account for legislation restricting opioid prescribing that went into effect during the study period. In recent years over 30 states have enacted laws limiting the supply of opioids that can be prescribed in the acute setting.<sup><xref rid="R46" ref-type="bibr">46</xref></sup> However, by comparing Michigan with a representative sample of patients from all other 49 states, we believe that the impact of these laws would be evenly distributed across groups. Moreover, multiple prior studies suggest that policies limiting opioid prescribing had little to no effect on postoperative prescribing practice, likely because the amount needed for these operations is far below the typical 7-day limit imposed by these policies.<sup><xref rid="R47" ref-type="bibr">47</xref>&#8211;<xref rid="R49" ref-type="bibr">49</xref></sup> Other guidelines were also released during this time, however, OPEN guidelines were formally endorsed and promoted by the MSQC and have previously been shown to have substantial adoption in Michigan.<sup><xref rid="R50" ref-type="bibr">50</xref></sup> The generalizability of this study may be limited by the use of Medicare claims, which typically include older patients in whom opioid use and risk factors differ from other patient cohorts. Another limitation is that this study did not assess patient-reported outcomes, although we previously found that patient-reported satisfaction and pain control remained unchanged after the implementation of these guidelines.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> This study also did not include trends in opioid use and prescribing after 2019, which are equally important to evaluate to understand the sustainability and long-term effect of these guidelines. Finally, although we used a widely accepted definition of new persistent opioid use, this definition may nevertheless identify patients who continue filling opioids after surgery for reasons unrelated to their operation, such as a new diagnosis.<sup><xref rid="R51" ref-type="bibr">51</xref></sup> Longitudinal studies of opioid-naive patients exposed to opioids perioperatively will be necessary to understand the trajectory of long-term opioid use after surgery.</p></sec><sec sec-type="conclusions"><title>CONCLUSIONS</title><p>Evidence-based prescribing guidelines were associated with a significant reduction in the incidence of new persistent opioid use and the quantity of opioids prescribed after surgery. Specifically, new persistent opioid use decreased by an additional 0.53 (95% CI 0.36-0.69) percentage points, and postoperative opioid prescription quantity decreased by an additional 55.7 (95% CI 46.5-65.4) mg OME in Michigan compared with the rest of the United States following guideline release. These results suggest that these prescribing guidelines may play an important role in protecting patients against opioid-related morbidity after surgery.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><fig id="s001" position="anchor" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sla-278-0216-s001.docx" position="float" orientation="portrait"/></fig></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>The authors thank the staff of the Michigan Surgical Quality Collaborative and Opioid Prescribing and Engagement Network in conducting the work described in this study.</p></ack><fn-group><fn fn-type="other"><p>H.M.H. had full access to all the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis.</p></fn><fn fn-type="COI-statement"><p>R.H. receives unrelated funding for research from Blue Cross Blue Shield of Michigan Foundation and the National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK108740-05). A.R., H.M.H., and C.S.B. have no disclosures. J.W., M.C.B., M.E., and C.M.B. receive funding from the Michigan Department of Health and Human Services and the National Institute on Drug Abuse (R01DA042859). M.B. reports past consultation with Axial Healthcare and Alosa Health not related to this work. C.S.B. is a consultant for Heron Therapeutics, Vertex Pharmaceuticals, Alosa Health, and the Benter Foundation, not related to this work. He also provides expert testimony.</p></fn><fn fn-type="supplementary-material"><p>Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.annalsofsurgery.com" ext-link-type="uri">www.annalsofsurgery.com</ext-link>.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>EC</given-names></name><name name-style="western"><surname>Darnall</surname><given-names>BD</given-names></name><name name-style="western"><surname>Baker</surname><given-names>LC</given-names></name><etal/></person-group>. <article-title>Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period</article-title>. <source>JAMA Inter Med</source>. <year>2016</year>;<volume>176</volume>:<fpage>1286</fpage>&#8211;<lpage>1293</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2016.3298</pub-id><pub-id pub-id-type="pmcid">PMC6684468</pub-id><pub-id pub-id-type="pmid">27400458</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>H</given-names></name><name name-style="western"><surname>Soneji</surname><given-names>N</given-names></name><name name-style="western"><surname>Ko</surname><given-names>DT</given-names></name><etal/></person-group>. <article-title>Rates and risk factors for prolonged opioid use after major surgery: population based cohort study</article-title>. <source>BMJ</source>. <year>2014</year>;<volume>348</volume>:<fpage>g1251</fpage>.<pub-id pub-id-type="pmid">24519537</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.g1251</pub-id><pub-id pub-id-type="pmcid">PMC3921439</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></name><name name-style="western"><surname>Goesling</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>New persistent opioid use after minor and major surgical procedures in US Adults</article-title>. <source>JAMA Surg</source>. <year>2017</year>;<volume>152</volume>:<fpage>e170504</fpage>.<pub-id pub-id-type="pmid">28403427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2017.0504</pub-id><pub-id pub-id-type="pmcid">PMC7050825</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hah</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>BT</given-names></name><name name-style="western"><surname>Ratliff</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic</article-title>. <source>Anesth Analg</source>. <year>2017</year>;<volume>125</volume>:<fpage>1733</fpage>&#8211;<lpage>1740</lpage>.<pub-id pub-id-type="pmid">29049117</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ANE.0000000000002458</pub-id><pub-id pub-id-type="pmcid">PMC6119469</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babu</surname><given-names>KM</given-names></name><name name-style="western"><surname>Brent</surname><given-names>J</given-names></name><name name-style="western"><surname>Juurlink</surname><given-names>DN</given-names></name></person-group>. <article-title>Prevention of opioid overdose</article-title>. <source>N Engl J Med</source>. <year>2019</year>;<volume>380</volume>:<fpage>2246</fpage>&#8211;<lpage>2255</lpage>.<pub-id pub-id-type="pmid">31167053</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra1807054</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Evans-Shields</surname><given-names>J</given-names></name><name name-style="western"><surname>England</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients</article-title>. <source>J Manag Care Spec Pharm</source>. <year>2021</year>;<volume>27</volume>:<fpage>760</fpage>&#8211;<lpage>771</lpage>.<pub-id pub-id-type="pmid">33624534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18553/jmcp.2021.20507</pub-id><pub-id pub-id-type="pmcid">PMC8177715</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brescia</surname><given-names>AA</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></name><name name-style="western"><surname>Hu</surname><given-names>HM</given-names></name><etal/></person-group>. <article-title>Impact of prescribing on new persistent opioid use after cardiothoracic surgery</article-title>. <source>Ann Thorac Surg</source>. <year>2019</year>;<volume>108</volume>:<fpage>1107</fpage>&#8211;<lpage>1113</lpage>.<pub-id pub-id-type="pmid">31447051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.athoracsur.2019.06.019</pub-id><pub-id pub-id-type="pmcid">PMC6755048</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilton</surname><given-names>J</given-names></name><name name-style="western"><surname>Abdia</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chong</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study</article-title>. <source>BMJ</source>. <year>2021</year>;<volume>375</volume>:<fpage>e066965</fpage>.<pub-id pub-id-type="pmid">34794949</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2021-066965</pub-id><pub-id pub-id-type="pmcid">PMC8600402</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aalberg</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Kimball</surname><given-names>MD</given-names></name><name name-style="western"><surname>McIntire</surname><given-names>TR</given-names></name><etal/></person-group>. <article-title>Long-term outcomes of persistent post-operative opioid use: a retrospective cohort study</article-title>. <source>Ann Surg</source>. <year>2022</year>. doi:<pub-id pub-id-type="doi">10.1097/sla.0000000000005372</pub-id><pub-id pub-id-type="pmid">35081575</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Vu</surname><given-names>JV</given-names></name><name name-style="western"><surname>Edelman</surname><given-names>AL</given-names></name><etal/></person-group>. <article-title>Health care spending and new persistent opioid use after surgery</article-title>. <source>Ann Surg</source>. <year>2020</year>;<volume>272</volume>:<fpage>99</fpage>&#8211;<lpage>104</lpage>.<pub-id pub-id-type="pmid">31851641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0000000000003399</pub-id><pub-id pub-id-type="pmcid">PMC7068728</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klueh</surname><given-names>MP</given-names></name><name name-style="western"><surname>Hu</surname><given-names>HM</given-names></name><name name-style="western"><surname>Howard</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Transitions of care for postoperative opioid prescribing in previously opioid-naive patients in the USA: a Retrospective Review</article-title>. <source>J Gen Intern Med</source>. <year>2018</year>;<volume>33</volume>:<fpage>1685</fpage>&#8211;<lpage>1691</lpage>.<pub-id pub-id-type="pmid">29948809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-018-4463-1</pub-id><pub-id pub-id-type="pmcid">PMC6153216</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="other"><collab>Prescribing Recommendations</collab>. <comment>Michigan OPEN</comment>. <comment>Accessed September 12, 2021.</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://michigan-open.org/prescribing-recommendations/" ext-link-type="uri">https://michigan-open.org/prescribing-recommendations/</ext-link><comment>Published 2020</comment>.</mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>R</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>J</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Reduction in opioid prescribing through evidence-based prescribing guidelines</article-title>. <source>JAMA Surg</source>. <year>2018</year>;<volume>153</volume>:<fpage>285</fpage>&#8211;<lpage>287</lpage>.<pub-id pub-id-type="pmid">29214318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2017.4436</pub-id><pub-id pub-id-type="pmcid">PMC5885924</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Overton</surname><given-names>HN</given-names></name><name name-style="western"><surname>Hanna</surname><given-names>MN</given-names></name><name name-style="western"><surname>Bruhn</surname><given-names>WE</given-names></name><etal/></person-group>. <article-title>Opioid-Prescribing guidelines for common surgical procedures: An expert panel consensus</article-title>. <source>J Am Coll Surg</source>. <year>2018</year>;<volume>227</volume>:<fpage>411</fpage>&#8211;<lpage>418</lpage>.<pub-id pub-id-type="pmid">30118896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jamcollsurg.2018.07.659</pub-id><pub-id pub-id-type="pmcid">PMC6353661</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hallway</surname><given-names>A</given-names></name><name name-style="western"><surname>Vu</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Patient satisfaction and pain control using an opioid-sparing postoperative pathway</article-title>. <source>J Am Coll Surg</source>. <year>2019</year>;<volume>229</volume>:<fpage>316</fpage>&#8211;<lpage>322</lpage>.<pub-id pub-id-type="pmid">31154092</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jamcollsurg.2019.04.020</pub-id><pub-id pub-id-type="pmcid">PMC7596906</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vu</surname><given-names>JV</given-names></name><name name-style="western"><surname>Howard</surname><given-names>RA</given-names></name><name name-style="western"><surname>Gunaseelan</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Statewide implementation of postoperative opioid prescribing guidelines</article-title>. <source>N Engl J Med</source>. <year>2019</year>;<volume>381</volume>:<fpage>680</fpage>&#8211;<lpage>682</lpage>.<pub-id pub-id-type="pmid">31412184</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMc1905045</pub-id><pub-id pub-id-type="pmcid">PMC7160762</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>R</given-names></name><name name-style="western"><surname>Brown</surname><given-names>CS</given-names></name><name name-style="western"><surname>Lai</surname><given-names>YL</given-names></name><etal/></person-group>. <article-title>The association of postoperative opioid prescriptions with patient outcomes</article-title>. <source>Ann Surg</source>. <year>2021</year>;<volume>276</volume>:<fpage>e1076</fpage>&#8211;<lpage>e1082</lpage>.<pub-id pub-id-type="pmid">34091508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0000000000004965</pub-id><pub-id pub-id-type="pmcid">PMC8787466</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Schwartzman</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Ambulatory surgery data from hospitals and ambulatory surgery centers: United States, 2010</article-title>. <source>Natl Health Stat Report</source>. <year>2017</year>;<volume>102</volume>:<fpage>1</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="pmid">28256998</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>R</given-names></name><name name-style="western"><surname>Fry</surname><given-names>B</given-names></name><name name-style="western"><surname>Gunaseelan</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Association of opioid prescribing with opioid consumption after surgery in Michigan</article-title>. <source>JAMA Surg</source>. <year>2019</year>;<volume>154</volume>:<fpage>e184234</fpage>.<pub-id pub-id-type="pmid">30422239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2018.4234</pub-id><pub-id pub-id-type="pmcid">PMC6439853</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>R</given-names></name><name name-style="western"><surname>Vu</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>A pathway for developing postoperative opioid prescribing best practices</article-title>. <source>Ann Surg</source>. <year>2020</year>;<volume>271</volume>:<fpage>86</fpage>&#8211;<lpage>93</lpage>.<pub-id pub-id-type="pmid">31478976</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0000000000003434</pub-id><pub-id pub-id-type="pmcid">PMC7106149</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>DA</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Kubus</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Henke</surname><given-names>PK</given-names></name><etal/></person-group>. <article-title>The Michigan surgical quality collaborative: a legacy of Shukri Khuri</article-title>. <source>Am J Surg</source>. <year>2009</year>;<volume>198</volume>(<issue>5 suppl</issue>):<fpage>S49</fpage>&#8211;<lpage>S55</lpage>.<pub-id pub-id-type="pmid">19874935</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjsurg.2009.08.002</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santosa</surname><given-names>KB</given-names></name><name name-style="western"><surname>Hu</surname><given-names>HM</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><etal/></person-group>. <article-title>New persistent opioid use among older patients following surgery: A Medicare claims analysis</article-title>. <source>Surgery</source>. <year>2020</year>;<volume>167</volume>:<fpage>732</fpage>&#8211;<lpage>742</lpage>.<pub-id pub-id-type="pmid">31349994</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.surg.2019.04.016</pub-id><pub-id pub-id-type="pmcid">PMC7216555</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>R</given-names></name><name name-style="western"><surname>Brown</surname><given-names>CS</given-names></name><name name-style="western"><surname>Lai</surname><given-names>YL</given-names></name><etal/></person-group>. <article-title>Postoperative opioid prescribing and new persistent opioid use: the risk of excessive prescribing</article-title>. <source>Ann Surg</source>. <year>2022</year>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0000000000005392</pub-id><pub-id pub-id-type="pmcid">PMC10537242</pub-id><pub-id pub-id-type="pmid">35129474</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gammaitoni</surname><given-names>AR</given-names></name><name name-style="western"><surname>Fine</surname><given-names>P</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Clinical application of opioid equianalgesic data</article-title>. <source>Clin J Pain</source>. <year>2003</year>;<volume>19</volume>:<fpage>286</fpage>&#8211;<lpage>297</lpage>.<pub-id pub-id-type="pmid">12966254</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00002508-200309000-00002</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Walraven</surname><given-names>C</given-names></name><name name-style="western"><surname>Austin</surname><given-names>PC</given-names></name><name name-style="western"><surname>Jennings</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data</article-title>. <source>Med Care</source>. <year>2009</year>;<volume>47</volume>:<fpage>626</fpage>&#8211;<lpage>633</lpage>.<pub-id pub-id-type="pmid">19433995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MLR.0b013e31819432e5</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bicket</surname><given-names>MC</given-names></name><name name-style="western"><surname>Brat</surname><given-names>GA</given-names></name><name name-style="western"><surname>Hutfless</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Optimizing opioid prescribing and pain treatment for surgery: Review and conceptual framework</article-title>. <source>Am J Health Syst Pharm</source>. <year>2019</year>;<volume>76</volume>:<fpage>1403</fpage>&#8211;<lpage>1412</lpage>.<pub-id pub-id-type="pmid">31505561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajhp/zxz146</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="other"><comment><italic toggle="yes">Framing Opioid Prescribing Guidelines for Acute Pain: Developing the Evidence</italic>. 2019</comment>.<pub-id pub-id-type="pmid">32182005</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dimick</surname><given-names>JB</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>AM</given-names></name></person-group>. <article-title>Methods for evaluating changes in health care policy: the difference-in-differences approach</article-title>. <source>JAMA</source>. <year>2014</year>;<volume>312</volume>:<fpage>2401</fpage>&#8211;<lpage>2402</lpage>.<pub-id pub-id-type="pmid">25490331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2014.16153</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keller</surname><given-names>DS</given-names></name><name name-style="western"><surname>Kenney</surname><given-names>BC</given-names></name><name name-style="western"><surname>Harbaugh</surname><given-names>CM</given-names></name><etal/></person-group>. <article-title>A national evaluation of opioid prescribing and persistent use after ambulatory anorectal surgery</article-title>. <source>Surgery</source>. <year>2021</year>;<volume>169</volume>:<fpage>759</fpage>&#8211;<lpage>766</lpage>.<pub-id pub-id-type="pmid">33288211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.surg.2020.11.006</pub-id><pub-id pub-id-type="pmcid">PMC8194057</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodman-Bacon</surname><given-names>A</given-names></name></person-group>. <article-title>Difference-in-differences with variation in treatment timing</article-title>. <source>J Econometr</source>. <year>2021</year>;<volume>225</volume>:<fpage>254</fpage>&#8211;<lpage>277</lpage>.</mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Elm</surname><given-names>E</given-names></name><name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>Lancet</source>. <year>2007</year>;<volume>370</volume>:<fpage>1453</fpage>&#8211;<lpage>1457</lpage>.<pub-id pub-id-type="pmid">18064739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(07)61602-X</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ladha</surname><given-names>KS</given-names></name><name name-style="western"><surname>Neuman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Broms</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Opioid prescribing after surgery in the United States, Canada, and Sweden</article-title>. <source>JAMA Netw Open</source>. <year>2019</year>;<volume>2</volume>:<fpage>e1910734</fpage>.<pub-id pub-id-type="pmid">31483475</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2019.10734</pub-id><pub-id pub-id-type="pmcid">PMC6727684</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaafarani</surname><given-names>HMA</given-names></name><name name-style="western"><surname>Han</surname><given-names>K</given-names></name><name name-style="western"><surname>El Moheb</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Opioids after surgery in the United States versus the rest of the world: The International Patterns of Opioid Prescribing (iPOP) Multicenter Study</article-title>. <source>Ann Surg</source>. <year>2020</year>;<volume>272</volume>:<fpage>879</fpage>&#8211;<lpage>886</lpage>.<pub-id pub-id-type="pmid">32657939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0000000000004225</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wunsch</surname><given-names>H</given-names></name><name name-style="western"><surname>Wijeysundera</surname><given-names>DN</given-names></name><name name-style="western"><surname>Passarella</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>315</volume>:<fpage>1654</fpage>&#8211;<lpage>1657</lpage>.<pub-id pub-id-type="pmid">26978756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2016.0130</pub-id><pub-id pub-id-type="pmcid">PMC4837043</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bicket</surname><given-names>MC</given-names></name><name name-style="western"><surname>Long</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Pronovost</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>Prescription opioid analgesics commonly unused after surgery: a systematic review</article-title>. <source>JAMA Surg</source>. <year>2017</year>;<volume>152</volume>:<fpage>1066</fpage>&#8211;<lpage>1071</lpage>.<pub-id pub-id-type="pmid">28768328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2017.0831</pub-id><pub-id pub-id-type="pmcid">PMC5701659</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larach</surname><given-names>DB</given-names></name><name name-style="western"><surname>Hah</surname><given-names>JM</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name></person-group>. <article-title>Perioperative opioids, the opioid crisis, and the anesthesiologist</article-title>. <source>Anesthesiology</source>. <year>2022</year>;<volume>136</volume>:<fpage>594</fpage>&#8211;<lpage>608</lpage>.<pub-id pub-id-type="pmid">35108351</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ALN.0000000000004109</pub-id><pub-id pub-id-type="pmcid">PMC8904272</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jivraj</surname><given-names>NK</given-names></name><name name-style="western"><surname>Raghavji</surname><given-names>F</given-names></name><name name-style="western"><surname>Bethell</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Persistent postoperative opioid use: A systematic literature search of definitions and population-based cohort study</article-title>. <source>Anesthesiology</source>. <year>2020</year>;<volume>132</volume>:<fpage>1528</fpage>&#8211;<lpage>1539</lpage>.<pub-id pub-id-type="pmid">32243330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ALN.0000000000003265</pub-id><pub-id pub-id-type="pmcid">PMC8202398</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kharasch</surname><given-names>ED</given-names></name><name name-style="western"><surname>Clark</surname><given-names>JD</given-names></name></person-group>. <article-title>Persistent postoperative opioid use: perception, progress, and promise</article-title>. <source>Anesthesiology</source>. <year>2020</year>;<volume>132</volume>:<fpage>1304</fpage>&#8211;<lpage>1306</lpage>.<pub-id pub-id-type="pmid">32243331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ALN.0000000000003298</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harbaugh</surname><given-names>CM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Hu</surname><given-names>HM</given-names></name><etal/></person-group>. <article-title>Persistent opioid use among pediatric patients after surgery</article-title>. <source>Pediatrics</source>. <year>2018</year>;<volume>141</volume>:<fpage>2017</fpage>&#8211;<lpage>2439</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2017-2439</pub-id><pub-id pub-id-type="pmcid">PMC7053700</pub-id><pub-id pub-id-type="pmid">29203521</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>R</given-names></name><name name-style="western"><surname>Gunaseelan</surname><given-names>V</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>New persistent opioid use after inguinal hernia repair</article-title>. <source>Ann Surg</source>. <year>2020</year>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0000000000004560</pub-id><pub-id pub-id-type="pmcid">PMC8289484</pub-id><pub-id pub-id-type="pmid">33065653</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garg</surname><given-names>RK</given-names></name><name name-style="western"><surname>Fulton-Kehoe</surname><given-names>D</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>GM</given-names></name></person-group>. <article-title>Patterns of opioid use and risk of opioid overdose death among medicaid patients</article-title>. <source>Med Care</source>. <year>2017</year>;<volume>55</volume>:<fpage>661</fpage>&#8211;<lpage>668</lpage>.<pub-id pub-id-type="pmid">28614178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MLR.0000000000000738</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>A</given-names></name><name name-style="western"><surname>Milne</surname><given-names>B</given-names></name><name name-style="western"><surname>Jamali</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Chronic opioid use after joint replacement surgery in seniors is associated with increased healthcare utilization and costs: a historical cohort study</article-title>. <source>Can J Anesth/J Can Anesth</source>. <year>2022</year>;<volume>69</volume>:<fpage>963</fpage>&#8211;<lpage>973</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12630-022-02240-1</pub-id><pub-id pub-id-type="pmid">35314993</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peahl</surname><given-names>AF</given-names></name><name name-style="western"><surname>Dalton</surname><given-names>VK</given-names></name><name name-style="western"><surname>Montgomery</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>Rates of new persistent opioid use after vaginal or cesarean birth among US women</article-title>. <source>JAMA Netw Open</source>. <year>2019</year>;<volume>2</volume>:<fpage>e197863</fpage>.<pub-id pub-id-type="pmid">31348508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2019.7863</pub-id><pub-id pub-id-type="pmcid">PMC6661716</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="other"><comment>Substance Use and Mental Disorders in the Detroit-Warren-Livonia MSA Population Estimates. 2005. Accessed March 2, 2022. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.samhsa.gov/data/sites/default/files/NSDUHMetroBriefReports/NSDUHMetroBriefReports/NSDUH-Metro-Detroit.pdf" ext-link-type="uri">https://www.samhsa.gov/data/sites/default/files/NSDUHMetroBriefReports/NSDUHMetroBriefReports/NSDUH-Metro-Detroit.pdf</ext-link></comment>.</mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>M</given-names></name><name name-style="western"><surname>Hallway</surname><given-names>A</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Patient-reported outcomes after opioid-sparing surgery compared with standard of care</article-title>. <source>JAMA Surg</source>. <year>2021</year>;<volume>156</volume>:<fpage>286</fpage>&#8211;<lpage>287</lpage>.<pub-id pub-id-type="pmid">33502440</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2020.5646</pub-id><pub-id pub-id-type="pmcid">PMC7841573</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>CS</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Hernandez-Delgado</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review</article-title>. <source>Drug Alcohol Depend</source>. <year>2019</year>;<volume>194</volume>:<fpage>166</fpage>&#8211;<lpage>172</lpage>.<pub-id pub-id-type="pmid">30445274</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2018.09.022</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chua</surname><given-names>KP</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></name></person-group>. <article-title>Opioid prescribing limits for acute pain: Potential problems with design and implementation</article-title>. <source>JAMA</source>. <year>2019</year>;<volume>321</volume>:<fpage>643</fpage>&#8211;<lpage>644</lpage>.<pub-id pub-id-type="pmid">30703214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2019.0010</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agarwal</surname><given-names>S</given-names></name><name name-style="western"><surname>Bryan</surname><given-names>JD</given-names></name><name name-style="western"><surname>Hu</surname><given-names>HM</given-names></name><etal/></person-group>. <article-title>Association of state opioid duration limits with postoperative opioid prescribing</article-title>. <source>JAMA Netw Open</source>. <year>2019</year>;<volume>2</volume>:<fpage>e1918361</fpage>.<pub-id pub-id-type="pmid">31880801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2019.18361</pub-id><pub-id pub-id-type="pmcid">PMC6991309</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>EC</given-names></name><name name-style="western"><surname>Rishel</surname><given-names>CA</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></name><etal/></person-group>. <article-title>Association between state limits on opioid prescribing and the incidence of persistent postoperative opioid use among surgical patients</article-title>. <source>Ann Surg</source>. <year>2021</year>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0000000000005283</pub-id><pub-id pub-id-type="pmcid">PMC9081293</pub-id><pub-id pub-id-type="pmid">35129496</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>CS</given-names></name><name name-style="western"><surname>Vu</surname><given-names>JV</given-names></name><name name-style="western"><surname>Howard</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Assessment of a quality improvement intervention to decrease opioid prescribing in a regional health system</article-title>. <source>BMJ Qual Saf</source>. <year>2021</year>;<volume>30</volume>:<fpage>251</fpage>&#8211;<lpage>259</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjqs-2020-011295</pub-id><pub-id pub-id-type="pmcid">PMC8056599</pub-id><pub-id pub-id-type="pmid">32938775</pub-id></mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barth</surname><given-names>RJJ</given-names></name><name name-style="western"><surname>Porter</surname><given-names>ED</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>JL</given-names></name><etal/></person-group>. <article-title>Reasons for long-term opioid prescriptions after guideline-directed opioid prescribing and excess opioid pill disposal</article-title>. <source>Ann Surg</source>. <year>2021</year>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0000000000004967</pub-id><pub-id pub-id-type="pmid">36827492</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>